Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
, 6, 239-45

Treatment of Chronic Regional Pain Syndrome Type 1 With Palmitoylethanolamide and Topical Ketamine Cream: Modulation of Nonneuronal Cells

Affiliations
Case Reports

Treatment of Chronic Regional Pain Syndrome Type 1 With Palmitoylethanolamide and Topical Ketamine Cream: Modulation of Nonneuronal Cells

Jan M Keppel Hesselink et al. J Pain Res.

Abstract

Chronic regional pain syndrome (CRPS) can be intractable to treat and patients sometimes suffer for many years. Therefore, new treatment strategies are needed to alleviate symptoms in CRPS patients. This case report describes a patient suffering from intractable CRPS type 1 for 13 years. Due to her swollen painful feet and left knee she is wheelchair-bound. The combination of palmitoylethanolamide and ketamine 10% cream reduced her pain by more than 50% after 1 month of treatment, and a marked reduction in swelling and skin discoloration was noticed. Furthermore, she could walk independently again and she experienced no side effects. Thus, palmitoylethanolamide and topical ketamine could be a combination therapy option for treating CRPS patients.

Keywords: CRPS; cream; endocannabinoid; ketamine; mast cells; palmitoylethanolamide; sudeck.

Figures

Figure 1
Figure 1
Chronic regional pain syndrome in the patient’s feet. (A) Before treatment. (B) After treatment with 10% ketamine cream and palmitoylethanolamide.

Similar articles

See all similar articles

Cited by 8 PubMed Central articles

See all "Cited by" articles

References

    1. Moskovitz PA. An overview of CRPS. Pract Pain Manag. 2010;10(1):47–51.
    1. Cossins L, Okell RW, Cameron H, Simpson B, Poole HM, Goebel A. Treatment of complex regional pain syndrome in adults: s systematic review of randomized controlled trials published from Jun 2000 to Feb 2012. Eur J Pain. 2012;17(2):158–173. - PubMed
    1. Tran de QH, Duong S, Bertini P, Finlayson RJ. Treatment of complex regional pain syndrome: a review of the evidence. Can J Anaesth. 2010;57(2):149–166. - PubMed
    1. Argoff CE, Albrecht P, Irving G, Rice F. Multimodal analgesia for chronic pain: rationale and future directions. Pain Med. 2009;10(Suppl 2):S53–S66. - PubMed
    1. Attal N, Bennett DLH, Treede RD. Neuropathic pain update: from basic mechanisms to clinical management. In: Tracey I, editor. Pain 2012 Refresher Courses, 14th World Congress of Pain. Seattle, WA: IASP Press; 2012. pp. 85–107.

Publication types

LinkOut - more resources

Feedback